Generally, our results showed that TIGIT expression was significantly correlated with many immune checkpoints in diverse immunocytes and distinct T cells, such as the positive correlation of TIGIT with CTLA4, PDCD1 (PD-1), CD274 (PD-L1), ICOS in most of the cancer types, implying a comprehensive co-expressing landscape. Here, CD274 is linked to cancer.